Syneos Health Inc (SYNH.O), a U.S. contract research organization (CRO) that serves the pharmaceutical industry, is exploring a sale, people familiar with the matter said on Monday. A deal for Syneos would be the latest in string of acquisitions of CROs, which have benefited in recent years from pharmaceutical companies’ drive to cut costs, reduce clinical trial times and expand their research and development presence around the world. Several drugmakers have pledged to research vaccines and therapeutics to combat the global coronavirus outbreak, suggesting than even in the event of a global economic slowdown, the demand for pharmaceutical services will remain strong. Based in Morrisville, North Carolina, Syneos specializes in helping companies with late-stage clinical trials. It was created by the merger of INC Research Holdings Inc and inVentiv Health in 2017.
Read the full article: Syneos Health Exploring a Sale: Sources //
Source: https://www.reuters.com/article/us-syneos-health-m-a-exclusive/exclusive-syneos-health-exploring-a-sale-sources-idUSKBN20W25G